close

Mergers and Acquisitions

1 2 3 33
Number of results: 647
Date Acquired company Acquiring company Amount Related
2018-10-26 Shire (UK - USA) Takeda Pharmaceutical (Japan) $ 62 billion Gastroinstestinal diseases - Neurosciences - Rare diseases - Genetic diseases - Immunological diseases
2018-10-18 Endocyte (USA - IN) Novartis (Switzerland) $ 2.1 billion Cancer - Oncology
2018-10-09 Vector Neurosciences (UK) MeiraGTx (USA - NY) Neurodegenerative diseases - CNS diseases
2018-10-01 Sanofi’s inhalation contract manufacturing business Recipharm (Sweden) undisclosed Technology - Services
2018-09-26 Syntimmune (USA - MA) Alexion Pharmaceuticals (USA -MA) up to $1.2 billion Autoimmune diseases
2018-09-20 Celenex Amicus Therapeutics (USA - NJ) $100 million in an upfront cash payment and up to $15 million in development milestones and $262 million in BLA/MAA submission and approval milestones Gene Therapy - Rare diseases - CNS diseases
2018-09-14 Bonti (USA - CA) Allergan (Ireland) $195 million and additional potential commercial milestone payments, subject to certain adjustments and other customary closing conditions aesthetic medicine
2018-09-13 Viratherapeutics (Austria) Boehringer Ingelheim (Germany) €210 million Cancer - Oncology
2018-09-06 Advanced Bioprocessing Business from BectonDickinson (USA - NJ) Thermo Fisher Scientific (USA - MA) Technology - Services
2018-09-06 sanaplasma AG (Switzerland) Shire (UK - USA)
2018-08-31 Shire's oncology business (UK-USA) Servier (France) $2.4 billion (€1.94 billion)
2018-08-31 Galderma R&D site in Sophia-Antipolis - Nestlé Skin Health (Switzerland) Nuvisan (Germany) CRO - analytical services
2018-07-24 Zavante Therapeutics (USA - CA) Nabriva Therapeutics (Ireland) up to $ 97.5 million Infectious diseases
2018-07-23 TxCell (France) Sangamo Therapeutics (USA - CA) € 72 million Cell therapy - CAR-T - Immunological diseases
2018-07-19 Agilis Biotherapeutics (USA - MA) PTC Therapeutics (USA - NJ) up to $260 million and success-based milestones Rare diseases - CNS Diseases - Gene therapy  
2018-06-16 Interactive Biosoftware (Frane) Sophia Genetics (France - Switzerland) undisclosed
2018-05-15 Avexis (USA - IL) Novartis (Switzerland) $ 8.7 billion Gene therapy - Neurodegenerative diseases - CNS diseases
2018-05-14 AurKa Pharma (Canada) Eli Lilly (USA - IN) up to $575 million Cancer - Oncology
2018-05-10 ARMO BioSciences (USA - CA) Eli Lilly (USA - IN) $1.6 billion Cancer - Oncology
2018-03-16 Prexton Therapeutics (Switzerland) Lundbeck (Denmark) up to € 905 million CNS diseases - Neurodegenerative diseases